Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Part of paid clinical trials in Jonesboro, Arkansas.
- Sponsor
- Vektor Medical
- Study ID
- NCT06935591
- Status
- Recruiting
Conditions
- Atrial Fibrillation (AF)
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Pulmonary Vein Isolation — PROCEDURESubjects will receive treatment for Atrial Fibrillation with Pulmonary Vein Isolation per standard of care.
- vMap® + Pulmonary Vein Isolation — DEVICESubjects will receive treatment for Atrial Fibrillation with the use of the vMap® system and Pulmonary Vein Isolation.
Study Details
The goal of this clinical trial is to compare the use of the Vektor Computational ECG Mapping System (vMap®) with pulmonary vein isolation (PVI), to using PVI alone, to treat Atrial Fibrillation (AF) in adults. Participants will have a 50/50 or 1 out of 2 chance of being placed in the treatment or control arm. The control arm of the study involves PVI alone for ablation procedure(s). The treatment arm involves the use of vMap mapping in addition to PVI to plan ablation procedure(s).
Key Dates
- Start date
- Jun 27, 2025
- Status verified
- Mar 2026
- Primary completion
- Oct 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 423 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: vMap®+PVISubjects in this arm will be treated with the use of the vMap® system in addition to pulmonary vein isolation.
- Active Comparator: PVI AloneSubjects in this arm will be treated with pulmonary vein isolation alone.
Primary Outcome Measure
Freedom from AF [ Time Frame: 12 months post procedure ]
Locations (12)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Arrhythmia Research Group - St. Bernards | Jonesboro | Arkansas | 72401 | Devi Nair, MD (PRINCIPAL_INVESTIGATOR) |
| BayCare Health System | Clearwater | Florida | 33759 | Vaibhav Moondra, MD (PRINCIPAL_INVESTIGATOR) Cydney Rebetti, APRN (SUB_INVESTIGATOR) |
| Baptist Health Jacksonville | Jacksonville | Florida | 32207 | Matthew S McKillop, MD (PRINCIPAL_INVESTIGATOR) Steven Ross, MD (SUB_INVESTIGATOR) Christopher Ruisi, MD (SUB_INVESTIGATOR) |
| USF Health | Tampa | Florida | 33606 | David Wilson, MD (PRINCIPAL_INVESTIGATOR) Bengt Herweg, MD (SUB_INVESTIGATOR) Christopher Cook, MD (SUB_INVESTIGATOR) |
| Piedmont Heart of Athens | Athens | Georgia | 30606 | Kent Nilsson, MD (PRINCIPAL_INVESTIGATOR) |
| Piedmont Heart Institute | Atlanta | Georgia | 30309 | Sandeep Goyal, MD (PRINCIPAL_INVESTIGATOR) Ashish Bhimani, MD (SUB_INVESTIGATOR) Michael Hoosien, MD (SUB_INVESTIGATOR) |
| Indiana University | Indianapolis | Indiana | 46202 | Mithilesh Das, MD (PRINCIPAL_INVESTIGATOR) John Miller, MD (SUB_INVESTIGATOR) |
| Baptist Health Lexignton | Lexington | Kentucky | 40503 | Gery Tomassoni, MD (PRINCIPAL_INVESTIGATOR) Johan Aasbo, MD (SUB_INVESTIGATOR) John Lee, MD (SUB_INVESTIGATOR) Joel Simon, MD (SUB_INVESTIGATOR) |
| Westchester Medical Center | Valhalla | New York | 10595 | Sei Iwai, MD (PRINCIPAL_INVESTIGATOR) Jason Jacobson, MD (SUB_INVESTIGATOR) Daniel Frenkel, MD (SUB_INVESTIGATOR) Rhadames Rojas, MD (SUB_INVESTIGATOR) Subrat Das, MD (SUB_INVESTIGATOR) Sade Solola-Nussbaum, MD (SUB_INVESTIGATOR) Sayaka Larsen, RN (SUB_INVESTIGATOR) Tracey Shannon, NP, RN (SUB_INVESTIGATOR) Nyree Sencion-Akhtar, DNP, FNP-C, RN (SUB_INVESTIGATOR) |
| OhioHealth | Columbus | Ohio | 43202 | Anish Amin, MD (PRINCIPAL_INVESTIGATOR) Sreedhar Billakanty, MD (SUB_INVESTIGATOR) Auroa Badin, MD (SUB_INVESTIGATOR) Nagesh Chopra, MD (SUB_INVESTIGATOR) Jaret Tyler, MD (SUB_INVESTIGATOR) Ankur Shah, MD (SUB_INVESTIGATOR) Eugene Fu, MD (SUB_INVESTIGATOR) |
| University of Toledo Medical Center | Toledo | Ohio | 43614 | Abhishek Maan, MD (PRINCIPAL_INVESTIGATOR) |
| Penn Presbyterian | Philadelphia | Pennsylvania | 19104-4238 | Benjamin D'Souza, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Jonesboro, AR
Related Studies
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)PHASE3 · Recruiting · Anthos Therapeutics, Inc. · Birmingham, Alabama
- COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG WearableEnrolling By Invitation · Peerbridge Health, Inc · Melbourne, Florida
- Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial FibrillationRecruiting · Arga Medtech SA · Birmingham, Alabama
- Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)Recruiting · McMaster University · Evanston, Illinois